The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis.

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications database > The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. > Access to Fulltext

Information
Files

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. - DKFZ-2025-02154

Main document file(s):

Similar records

DKFZ :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy